日本《腹膜播散诊疗指南(2021版)》解读OA北大核心CSTPCD

The"Clinical Practice Guidelines for Peritoneal Malignancy 2021",issued by the Japanese Society of Peritoneal Malignancy,is a highly authoritative and comprehensive guideline,formulated on the basis of extensive research and clinical experience.This guideline provides detailed explanations of the diagnosis and treatment options for patients with peritoneal dissemination caused by malignant tumors in the abdomen,serving as an important reference for doctors.In terms of surgery,the guideline emphasizes the importance of strict selection criteria to ensure surgical quality and effectiveness.With regard to chemotherapy,various drugs and protocols are introduced along with their methods of use and effects,providing comprehensive and accurate information for both doctors and patients.Additionally,this guideline specifies recommended approaches to clinical issues related to peritoneal dissemination diagnosis and treatment,further enhancing its guidance and reliability.Understanding this guideline will contribute to improving China's level of diagnosis and treatment for peritoneal malignancy,ultimately providing better medical services for patients.